MedTrace Logo

Lurasidone Non-Interventional Study in Schizophrenia Patients

NCT06527885 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2024-08-01

No results posted yet for this study

Summary

The study is a multicentric, national, non-interventional, prospective, single arm study.

The main goal of this study is to gather information about the effects, in a real-life setting, of lurasidone treatment on patient's reported outcomes, in terms of patient's treatment satisfaction, Quality of Life and functioning changes after 6 weeks from lurasidone treatment initiation in schizophrenia patients naïve to lurasidone.

Conditions

Interventions

DRUG

Lurasidone

Patients treated with Lurasidone in according to routine clinical practice, in Italy

Sponsors & Collaborators

  • Hippocrates Research

    collaborator OTHER

  • Aziende Chimiche Riunite Angelini Francesco S.p.A

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-21
Primary Completion
2023-09-12
Completion
2023-09-12

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06527885 on ClinicalTrials.gov